As of 2025-08-06, the Relative Valuation of BioPharma Credit PLC (BPCR.L) is 1.46 USD. This relative valuation is based on P/E multiples. With the latest stock price at 0.87 USD, the upside of BioPharma Credit PLC based on Relative Valuation is 67.8%.
The range of the Relative Valuation is 1.29 - 1.85 USD.
| Range | Selected | |
| Trailing P/E multiples | 13.7x - 17.1x | 14.0x |
| Forward P/E multiples | 14.0x - 19.0x | 15.4x |
| Fair Price | 1.29 - 1.85 | 1.46 |
| Upside | 47.7% - 112.7% | 67.8% |
| Date | P/E |
| 2025-08-05 | 8.06 |
| 2025-08-04 | 8.02 |
| 2025-08-01 | 8.04 |
| 2025-07-31 | 8.02 |
| 2025-07-30 | 8.08 |
| 2025-07-29 | 8.04 |
| 2025-07-28 | 8.08 |
| 2025-07-25 | 8.04 |
| 2025-07-24 | 8.08 |
| 2025-07-23 | 8.10 |
| 2025-07-22 | 8.12 |
| 2025-07-21 | 8.13 |
| 2025-07-18 | 8.15 |
| 2025-07-17 | 8.15 |
| 2025-07-16 | 8.15 |
| 2025-07-15 | 8.13 |
| 2025-07-14 | 8.13 |
| 2025-07-11 | 8.08 |
| 2025-07-10 | 8.13 |
| 2025-07-09 | 8.13 |
| 2025-07-08 | 8.13 |
| 2025-07-07 | 8.13 |
| 2025-07-04 | 8.13 |
| 2025-07-03 | 8.12 |
| 2025-07-02 | 8.13 |
| 2025-07-01 | 8.17 |
| 2025-06-30 | 8.17 |
| 2025-06-27 | 8.13 |
| 2025-06-26 | 8.13 |
| 2025-06-25 | 8.32 |
| 2025-06-24 | 8.25 |
| 2025-06-23 | 8.28 |
| 2025-06-20 | 8.34 |
| 2025-06-19 | 8.32 |
| 2025-06-18 | 8.34 |
| 2025-06-17 | 8.41 |
| 2025-06-16 | 8.37 |
| 2025-06-13 | 8.41 |
| 2025-06-12 | 8.32 |
| 2025-06-11 | 8.21 |
| 2025-06-10 | 8.12 |
| 2025-06-09 | 8.13 |
| 2025-06-06 | 8.08 |
| 2025-06-05 | 8.13 |
| 2025-06-04 | 8.10 |
| 2025-06-03 | 8.13 |
| 2025-06-02 | 8.13 |
| 2025-05-30 | 8.13 |
| 2025-05-29 | 8.13 |
| 2025-05-28 | 8.13 |